Phase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal cancer. [electronic resource]
Producer: 20121108Description: 1139-46.e2 p. digitalISSN:- 1097-6779
- Adenocarcinoma -- diagnostic imaging
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Squamous Cell -- diagnostic imaging
- Chemoradiotherapy, Adjuvant -- adverse effects
- Chills -- etiology
- Cisplatin -- administration & dosage
- Disease-Free Survival
- Dose Fractionation, Radiation
- Endosonography
- Esophageal Neoplasms -- diagnostic imaging
- Esophagectomy
- Esophagitis -- etiology
- Fatigue -- etiology
- Female
- Fever -- etiology
- Fluorouracil -- administration & dosage
- Humans
- Injections, Intralesional
- Kaplan-Meier Estimate
- Karnofsky Performance Status
- Male
- Maximum Tolerated Dose
- Middle Aged
- Nausea -- etiology
- Neoadjuvant Therapy -- adverse effects
- Thromboembolism -- etiology
- Transduction, Genetic
- Tumor Necrosis Factor-alpha -- administration & dosage
- Ultrasonography, Interventional
- Vomiting -- etiology
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.